Publications
1. Dellon ES, Lucendo AJ, Schlag AJ, et al. Fluticasone propionate orally disintegrating tablet (APT-1011) for eosinophilic esophagitis: randomized controlled trial. Clin Gastroenterol Hepatol. 2022;20(11):P2485-2494.E15. doi: 10.1016/j.cgh.2022.02.013 (hired editorial support)
2. Skoufalos A, N’Dri LA, Waters D. Leveraging digital medicine to support providers and their patients in managing serious mental illness. Population Health Manag. 2021;24(S2):S55-S61. doi: 10.1089/pop.2021.0083 (hired editorial support)
3. Anthony LB, O’Dorisio TM. Opportunities to improve symptom control with somatostatin congeners in GEP-NETs: a review of key issues. Oncologist. 2021. 18;26(7):e1171-e1178. dio: 10.1002/conc.13847 (hired editorial support)
4. Hirano I, Safroneeva E, Roumet MC, et al. Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis. Aliment Pharmacol Ther. 2020 Apr;51(8):750-759. doi: 10.1111/apt.15670 (hired editorial support)
5. Bushar ND, Corbo E, Schmidt M, et al. Ablation of SLP-76 signaling after T cell priming generated memory CD4 T cells impaired in steady-state and cytokine-driven homeostasis. Proc Natl Acad Sci. 2010;107(2):827-31. doi: 10.1073/pnas.0908126107
6. Shaffer MH, Huang Y, Corbo E, et al. Ezrin is highly expressed in early thymocytes, but dispensable for T cell development in mice. PloS One. 2010;5(8):e12404. doi: 10.1371/journal.pone.0012404
7. Wiehagen KR, Corbo E, Schmidt M, et al. Loss of tonic T-cell receptor signals alters the generation but not the persistence of CD8+ memory T cells. Blood. 2010;116(25):5560-70. doi: 10.1182/blood-2010-06-292458
8. Wu GF*, Corbo E*, Schmidt M, et al. Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responses. Eur J of Immunol. 2011;41(7):2064-73. doi: 10.1002/eji.201040809 *Equal Contribution
9. Burns JC, Corbo E, Anterasian C, et al. The SH2 domain of SLP-76 is required for thymocyte selection and PKD activation. J Immunol. 2011;187(9):4459-66. doi: 10.4049/jimmunol.0903379
10. Lieberman SM, Kim JS, Corbo-Rodgers E, et al. Site-specific accumulation of recently activated CD4+FoxP3+ regulatory T cells following adoptive transfer. Eur J Immunol. 2012;42(6):1429-35. doi: 10.1002/eji.201142286
11. Zou T, Satake A, Corbo-Rodgers E, et al. IL-2 signals determine the degree of TCR signaling necessary to support mouse regulatory T cell proliferation in vivo. J Immunol: Cutting Edge. 2012;189(1):28-32. doi: 10.4049/jimmunol.1200507 Cited in Faculty of 1000
12. Corbo-Rodgers E, Staub ES, Zou T, et al. Oral ivermectin as an unexpected initator of CreT2-mediated deletion in T cells. Nat Immunol. 2012;13(3):197-198. doi: 10.1038/ni.2232 Cited in Faculty of 1000
13. Wiehagen KR, Corbo-Rodgers E, Staub ES, et al. Foxp4 is dispensable for T cell development, but required for robust recall responses during chronic Toxoplasmosis. PLoS One. 2012;7(8):e42273. doi: 10.1371/journal.pone.0042273
14. Corbo-Rodgers E, Wiehagen KR, Staub ES, et al. Homeostatic division is not necessary for antigen-specific CD4+ memory T cell persistence. J Immunol. 2012;189(7):3378-85. doi: 10.4049/jimmunol.1201583